Canonical ingredient

2-Propanol, 1-[4-(2-methoxyethyl)phenoxy] -3-[(1-methylethyl)amino]-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)

METOPROLOL TARTRATE

94 linked products

Official identifiers

CAS 56392-17-7 ChEBI CHEBI:6906 InChI InChI=1S/2C15H25NO3.C4H6O6/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-1(3(7)8)2(6)4(9)10/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t;;1-,2-/m..1/s1 InChIKey YGULWPYYGQCFMP-CEAXSRTFSA-N SMILES COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O

Names and synonyms

2-Propanol, 1-[4-(2-methoxyethyl)phenoxy] -3-[(1-methylethyl)amino]-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt) (en)
Metoprolol tartrate (en)
Tartrate de métoprolol (fr)
1-[4-(2-méthoxyéthyl)phénoxy]-3-[(1-méthyléthyl)amino]propan-2-ol, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (sel) (fr-CA)

Source-scoped chemical properties

Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.

canada dsl listing: listed; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl bioaccumulative: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl inherently toxic aquatic: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets cepa categorization: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets environmental: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets human health: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl persistent: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl substance category: Organics; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)

No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Evidence still missing

Country or region of origin
Raw-material producer
Ingredient manufacturer
Distributor
Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

No organization has been proven yet by an explicit source.

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.

Products containing this ingredient

AA-METOPROLOL SR

AA-METOPROLOL SR

AG-METOPROLOL-L

AG-METOPROLOL-L

AG-METOPROLOL-L

APO-METOPROLOL (TYPE L)

APO-METOPROLOL (TYPE L)

AVA-METOPROLOL (TYPE L)

AVA-METOPROLOL (TYPE L)

BETALOC DURULES TAB 200 MG

200 · MG · SRT

BETALOC IV INJ 1 MG/ML

BETALOC TAB 100 MG

BETALOC TAB 50 MG

CO METOPROLOL-L TABLETS 100MG

CO METOPROLOL-L TABLETS 50MG

DOM-METOPROLOL-B - TAB 50MG

DOM-METOPROLOL-B TAB 100MG

DOM-METOPROLOL-L

DOM-METOPROLOL-L

DOM-METOPROLOL-L

GEN-METOPROLOL TABLETS 100MG

GEN-METOPROLOL TABLETS 50MG

JAMP-METOPROLOL-L

JAMP-METOPROLOL-L

JAMP-METOPROLOL-L

LOPRESOR INJ 1.0MG/ML

1 · MG · 1 · ML

LOPRESOR SR 100MG

LOPRESOR SR 200 MG

METOPROLOL TARTRATE INJECTION USP

1 · MG · 1 · ML

METOPROLOL TARTRATE INJECTION USP

METOPROLOL TARTRATE INJECTION USP

METOPROLOL TARTRATE INJECTION USP

METOPROLOL TARTRATE INJECTION, USP